HomeNewsBusinessEconomy‘Aatmanirbharta’ over export-orientation is ‘akin to killing the goose that lays the golden egg’: Arvind Subramanian

‘Aatmanirbharta’ over export-orientation is ‘akin to killing the goose that lays the golden egg’: Arvind Subramanian

In a research paper, former CEA argues that the Indian domestic market is still quite small, and is likely to remain so over the medium-term, since domestic demand will be weighed down by heavy debts across the economic horizon—in firms, households, and the government.

October 14, 2020 / 17:07 IST
Story continues below Advertisement

The government’s stance of prioritizing domestic demand over exports and abandoning export-orientation is detrimental for the country’s economy and "akin to killing the goose that lays the golden egg", former Chief Economic Advisor Arvind Subramanian has written in a research paper.

Subramanian, who is currently the director of the Ashoka Centre for Economic Policy, has co-authored the paper titled 'India’s Inward (Re)Turn: Is it Warranted? Will it Work?' with Shoumitro Chatterjee of Pennsylvania State University in the United States.

Story continues below Advertisement

"India is turning inward. Domestic demand is assuming primacy over export-orientation and trade restrictions are increasing, reversing a three-decade trend," the paper said.

The paper said that this shift was based on three misconceptions: that India’s domestic market size is big, India’s growth has been based on domestic not export markets, and export prospects are dim because the world is de-globalizing.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show